{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:37:02Z","timestamp":1790779022001,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Pediatrics\uff0cTianjin Medical University General Hospital","award":["22ZYYLCCG03"],"award-info":[{"award-number":["22ZYYLCCG03"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJWJ2022XK008, TJYXZDXK-068C"],"award-info":[{"award-number":["TJWJ2022XK008, TJYXZDXK-068C"]}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Plan Project","doi-asserted-by":"crossref","award":["22KPHDRC00120"],"award-info":[{"award-number":["22KPHDRC00120"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05703-8","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T21:35:24Z","timestamp":1746567324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Combination therapy of GnRHa, RhGH and anastrozole to improve final adult height deficit in CAH children with CPP"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaoxiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxiu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"4","key":"5703_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/cen.14960","volume":"101","author":"IA Bacila","year":"2024","unstructured":"Bacila IA, Lawrence NR, Badrinath SG, Balagamage C, Krone NP. Biomarkers in congenital adrenal hyperplasia. Clin Endocrinol. 2024;101(4):300\u201310.","journal-title":"Clin Endocrinol"},{"issue":"10","key":"5703_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W. EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur J Hum Genetics: EJHG. 2020;28(10):1341\u201367.","journal-title":"Eur J Hum Genetics: EJHG"},{"key":"5703_CR3","doi-asserted-by":"publisher","first-page":"1102741","DOI":"10.3389\/fendo.2023.1102741","volume":"14","author":"T Itonaga","year":"2023","unstructured":"Itonaga T, Hasegawa Y. Monitoring treatment in pediatric patients with 21-hydroxylase deficiency. Front Endocrinol. 2023;14:1102741.","journal-title":"Front Endocrinol"},{"issue":"2","key":"5703_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.beem.2008.09.010","volume":"23","author":"M Debono","year":"2009","unstructured":"Debono M, Price JN, Ross RJ. Novel strategies for hydrocortisone replacement. Best Pract Res Clin Endocrinol Metab. 2009;23(2):221\u201332.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"5703_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1210\/clinem\/dgad514","volume":"109","author":"ME Flokas","year":"2024","unstructured":"Flokas ME, Wakim P, Kollender S, Sinaii N, Merke DP. Gonadotropin-Releasing hormone agonist therapy and longitudinal bone mineral density in congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2024;109(2):498\u2013504.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"5703_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1515\/jpem-2015-0406","volume":"29","author":"L Juan","year":"2016","unstructured":"Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, et al. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China. J Pediatr Endocrinol Metabolism: JPEM. 2016;29(7):841\u20138.","journal-title":"J Pediatr Endocrinol Metabolism: JPEM"},{"issue":"4","key":"5703_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1542\/peds.106.4.767","volume":"106","author":"SA Rivkees","year":"2000","unstructured":"Rivkees SA, Crawford JD. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics. 2000;106(4):767\u201373.","journal-title":"Pediatrics"},{"issue":"6","key":"5703_CR8","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1210\/jc.2004-2128","volume":"90","author":"K Lin-Su","year":"2005","unstructured":"Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, et al. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2005;90(6):3318\u201325.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5703_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jfma.2022.09.007","volume":"122","author":"MM Tsai","year":"2023","unstructured":"Tsai MM, Tsai WY, Lee CT, Liu SY, Chien YH, Tung YC. Adult height of children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Formos Med Association = Taiwan Yi Zhi. 2023;122(2):106\u201312.","journal-title":"J Formos Med Association = Taiwan Yi Zhi"},{"issue":"27","key":"5703_CR10","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1097\/MD.0000000000000260","volume":"93","author":"P Li","year":"2014","unstructured":"Li P, Li Y, Yang CL. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis. Medicine. 2014;93(27):e260.","journal-title":"Medicine"},{"issue":"8","key":"5703_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1590\/S0004-27302011000800023","volume":"55","author":"CA Longui","year":"2011","unstructured":"Longui CA, Kochi C, Calliari LE, Modkovski MB, Soares M, Alves EF, et al. Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using GH and GnRHa. Arq Bras Endocrinol Metabol. 2011;55(8):661\u20134.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"5703_CR12","first-page":"1511","volume":"86","author":"JB Quintos","year":"2001","unstructured":"Quintos JB, Vogiatzi MG, Harbison MD, New MI. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86(4):1511\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5703_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1210\/jcem.85.3.6462","volume":"85","author":"DP Merke","year":"2000","unstructured":"Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB Jr. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2000;85(3):1114\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"5703_CR14","first-page":"Cd010888","volume":"201510","author":"N McGrath","year":"2015","unstructured":"McGrath N, O\u2019Grady MJ. Aromatase inhibitors for short stature in male children and adolescents. Cochrane Database Syst Rev. 2015;201510:Cd010888.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"5703_CR15","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-Hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(11):4043\u201388.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"5703_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S2352-4642(23)00237-7","volume":"7","author":"EL Zevin","year":"2023","unstructured":"Zevin EL, Eugster EA. Central precocious puberty: a review of diagnosis, treatment, and outcomes. Lancet Child Adolesc Health. 2023;7(12):886\u201396.","journal-title":"Lancet Child Adolesc Health"},{"issue":"19","key":"5703_CR17","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3390\/diagnostics13193124","volume":"13","author":"SE Mart\u00edn P\u00e9rez","year":"2023","unstructured":"Mart\u00edn P\u00e9rez SE, Mart\u00edn P\u00e9rez IM, Vega Gonz\u00e1lez JM, Molina Su\u00e1rez R, Le\u00f3n Hern\u00e1ndez C, Rodr\u00edguez Hern\u00e1ndez F, et al. Precision and accuracy of radiological bone age assessment in children among different ethnic groups: A systematic review. Diagnostics (Basel). 2023;13(19):3124.","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"5703_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0022-3476(52)80205-7","volume":"40","author":"N Bayley","year":"1952","unstructured":"Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952;40(4):423\u201341.","journal-title":"J Pediatr"},{"issue":"3","key":"5703_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1651-2227.1999.tb01091.x","volume":"88","author":"ZC Luo","year":"1999","unstructured":"Luo ZC, Low LC, Karlberg J. A comparison of target height estimated and final height attained between Swedish and Hong Kong Chinese children. Acta Paediatr (Oslo Norway: 1992). 1999;88(3):248\u201352.","journal-title":"Acta Paediatr (Oslo Norway: 1992)"},{"issue":"2","key":"5703_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12098-018-2753-6","volume":"86","author":"A Maheshwari","year":"2019","unstructured":"Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A. Long-term growth in congenital adrenal hyperplasia. Indian J Pediatr. 2019;86(2):154\u20138.","journal-title":"Indian J Pediatr"},{"issue":"6","key":"5703_CR21","doi-asserted-by":"publisher","first-page":"858","DOI":"10.4103\/ijem.IJEM_254_18","volume":"22","author":"D Dayal","year":"2018","unstructured":"Dayal D, Aggarwal A, Seetharaman K, Muthuvel B. Central precocious puberty complicating congenital adrenal hyperplasia: North Indian experience. Indian J Endocrinol Metabol. 2018;22(6):858\u20139.","journal-title":"Indian J Endocrinol Metabol"},{"key":"5703_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1749-6632.1985.tb14602.x","volume":"458","author":"OH Pescovitz","year":"1985","unstructured":"Pescovitz OH, Cassorla F, Comite F, Loriaux DL, Cutler GB Jr. LHRH analog treatment of central precocious puberty complicating congenital adrenal hyperplasia. Ann N Y Acad Sci. 1985;458:174\u201381.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"5703_CR23","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0929-6646(08)60047-9","volume":"106","author":"YC Tung","year":"2007","unstructured":"Tung YC, Lee JS, Tsai WY, Hsiao PH. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty. J Formos Med Association = Taiwan Yi Zhi. 2007;106(10):826\u201331.","journal-title":"J Formos Med Association = Taiwan Yi Zhi"},{"issue":"5","key":"5703_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0026-0495(97)90186-4","volume":"46","author":"AT Soliman","year":"1997","unstructured":"Soliman AT, AlLamki M, AlSalmi I, Asfour M. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metab Clin Exp. 1997;46(5):513\u20137.","journal-title":"Metab Clin Exp"},{"issue":"6","key":"5703_CR25","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1210\/jc.2010-2699","volume":"96","author":"K Lin-Su","year":"2011","unstructured":"Lin-Su K, Harbison MD, Lekarev O, Vogiatzi MG, New MI. Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. J Clin Endocrinol Metab. 2011;96(6):1710\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5703_CR26","first-page":"1271","volume":"37","author":"QF Wang","year":"2024","unstructured":"Wang QF, Xue WY, Zhao J. Effects of Recombinant human growth hormone injection combined with anastrozole on height and growth rate of adolescent idiopathic short stature and evaluation of adverse reactions. Pak J Pharm Sci. 2024;37(6):1271\u201380.","journal-title":"Pak J Pharm Sci"},{"issue":"9","key":"5703_CR27","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1210\/jc.2009-2616","volume":"95","author":"K Muthusamy","year":"2010","unstructured":"Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, et al. Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2010;95(9):4161\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"5703_CR28","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.1210\/jc.2016-2891","volume":"101","author":"N Mauras","year":"2016","unstructured":"Mauras N, Ross JL, Gagliardi P, Yu YM, Hossain J, Permuy J, et al. Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature. J Clin Endocrinol Metab. 2016;101(12):4984\u201393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"5703_CR29","doi-asserted-by":"publisher","first-page":"bvae141","DOI":"10.1210\/jendso\/bvae141","volume":"8","author":"W Zegarra","year":"2024","unstructured":"Zegarra W, Ranadive S, Toulan D, Neely EK. Anastrozole vs letrozole to augment height in pubertal males with idiopathic short stature: A 3-Year randomized trial. J Endocr Soc. 2024;8(10):bvae141.","journal-title":"J Endocr Soc"},{"issue":"1","key":"5703_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/cen.14009","volume":"91","author":"A Halper","year":"2019","unstructured":"Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: impact of anastrozole on bone mineral density and visceral adipose tissue. Clin Endocrinol. 2019;91(1):124\u201330.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"5703_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000501746","volume":"92","author":"WJ Goedegebuure","year":"2019","unstructured":"Goedegebuure WJ, Hokken-Koelega ACS. Aromatase inhibitor as treatment for severely advanced bone age in congenital adrenal hyperplasia: A case report. Hormone Res Paediatrics. 2019;92(3):209\u201313.","journal-title":"Hormone Res Paediatrics"},{"issue":"1","key":"5703_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12887-024-05301-0","volume":"24","author":"K Wang","year":"2024","unstructured":"Wang K, Ye F, Wang DY, Lai PJ, Zhang LQ. Aromatase inhibitors for short stature in male children and adolescents treated with growth hormone: a meta-analysis of randomized controlled trials. BMC Pediatr. 2024;24(1):813.","journal-title":"BMC Pediatr"},{"issue":"1","key":"5703_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12887-025-05408-y","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yuan X, McCormick K, Yang XH, Chen SJ, Chen RM. The efficacy and safety of RhGH treatment combined with Letrozole\/GnRHa in adolescent boys. BMC Pediatr. 2025;25(1):59.","journal-title":"BMC Pediatr"},{"key":"5703_CR34","doi-asserted-by":"publisher","first-page":"1101843","DOI":"10.3389\/fendo.2023.1101843","volume":"14","author":"SC Liu","year":"2023","unstructured":"Liu SC, Suresh M, Jaber M, Mercado Munoz Y, Sarafoglou K. Case report: anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia. Front Endocrinol. 2023;14:1101843.","journal-title":"Front Endocrinol"},{"key":"5703_CR35","doi-asserted-by":"crossref","unstructured":"Al-Rayess H, Wiersma R, Turner LE, Palzer E, Mercado Munoz Y, Sarafoglou K. Anastrozole improves height outcomes in growing children with congenital adrenal hyperplasia due to 21-OHD. J Clin Endocrinol Metab. 2024.","DOI":"10.1210\/clinem\/dgae771"},{"issue":"3","key":"5703_CR36","first-page":"302","volume":"49","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhang S, Ma X, Li G, Wang Z, Wang F. Efficacy of letrozole in treatment of children with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Zhejiang Da Xue Xue Bao Yi Xue ban = J Zhejiang Univ Med Sci. 2020;49(3):302\u20137.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue ban = J Zhejiang Univ Med Sci"},{"issue":"4","key":"5703_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40618-015-0399-z","volume":"39","author":"DT Papadimitriou","year":"2016","unstructured":"Papadimitriou DT, Dermitzaki E, Papagianni M, Papaioannou G, Papaevangelou V, Papadimitriou A. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the GAIL study. J Endocrinol Investig. 2016;39(4):439\u201346.","journal-title":"J Endocrinol Investig"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05703-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T21:35:26Z","timestamp":1746567326000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05703-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5703"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05703-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5573763\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by Ethics Committee of Academy of Tianjin Medical University General Hospital (ZYY-IRB-SOP-019(F)-002-02). As our study involved a retrospective database analysis, parental consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"362"}}